1. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbial Rev. 2006; 19 (2): 403-34. [
DOI:10.1128/CMR.19.2.403-434.2006]
2. Santucci SG, Gobara S, Santos CR, Fontana C, Levin AS. Infections in a burn intensive care unit: experience of seven years. J Hosp Infect. 2003; 53: 6-13. [
DOI:10.1053/jhin.2002.1340]
3. Pirnay JP, De Vos D, Cochez C, Bilocq F, Pirson J, Struelens M, et al. Molecular epidemiology of Pseudomonas aeroginosa colonization in a burn unit: persistence of multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbial. 2003; 41 (3): 1192-202. [
DOI:10.1128/JCM.41.3.1192-1202.2003]
4. Rodríguez-Rojas A, Bla'zquez J. The Pseudomonas aeruginosa pfpI gene plays an antimutator role and provides general stress protection. J Bacteriol. 2009: 844-850. [
DOI:10.1128/JB.01081-08]
5. Forbes BA, Sahm DF, Weissfeld AS. Diagnostic microbiology. Baily & Scott. 2007; 11th Ed. St. Louis, Mosb Inc: 389-397.
6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. (2012) 12th Informational Supplement. CLSI document M100-S12, vol. 22, No.1, Pennsylvania, USA.
7. Blazquez J. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin Infect Dis. 2003; 37: 1201-9. [
DOI:10.1086/378810]
8. Oliver A, Canton RP, Campo F, Baquero F, and Blazquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science. 2000; 288: 1251-4. [
DOI:10.1126/science.288.5469.1251]
9. Oliver A, Levin BR, Juan C, Baquero F, and Blazquez J. Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections. Antimicrob Agents Chemother. 2004; 48: 4226-33. [
DOI:10.1128/AAC.48.11.4226-4233.2004]
10. Macia MD, Blanquer D, Togores B, Sauleda J, Perez JL, and Oliver A. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother. 2005; 49: 3382-6. [
DOI:10.1128/AAC.49.8.3382-3386.2005]
11. Oliver A, Baquero F, and Blazquez J. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol Microbiol. 2002; 43: 1641-50. [
DOI:10.1046/j.1365-2958.2002.02855.x]
12. Ekrami A, and Kalantar E. Bacterial infection in burn patients at a burn hospital in Iran. Indian J Med Res. 2007; 126: 541-4.
13. Estahbanati HK, Kashani PP, Ghanaatpishe F. Frequency of Pseudomonas aeroginosa serotypes in burn wound infections and their resistance to antibiotics. Burns. 2002; 28: 340-8. [
DOI:10.1016/S0305-4179(02)00024-4]
14. Kovacs B, Le Gall-David S, Vincent P, Le Bars H, Buffet-Bataillon S, Bonnaure-Mallet M, et al. Is biofilm formation related to the hypermutator phenotype in clinical Enterobacteriaceae isolates? FEMS Microbiol Lett. 2013; 347 (2): 116-22 [
DOI:10.1111/1574-6968.12229]
15. Guelfo JR, Rodriguez-Rojas A, Matic I, Blazquez J. A MATE-family efflux pump rescues the Escherichia coli 8-oxoguanine-repair-deficient mutator phenotype and protects against H2O2 killing. PLoS Genetics. 2010; 6 (5). [
DOI:10.1371/journal.pgen.1000931]
16. Eschenlauer SC, Coombs GH, Mottram JC. PFPI-like genes are expressed in Leishmania major but are pseudogenes in other Leishmania species. FEMS Microbiol Lett. 2006; 260 (1): 47-54. [
DOI:10.1111/j.1574-6968.2006.00303.x]
17. Mandsberg LF, Maciá MD, Bergmann KR, Christiansen LE, Alhede M, Kirkby N, et al. Development of antibiotic resistance and up-regulation of the antimutator gene pfpI in mutator Pseudomonas aeruginosa due to inactivation of two DNA oxidative repair genes (mutY, mutM). FEMS Microbiol Lett. 2011; 324 (1): 28-37. [
DOI:10.1111/j.1574-6968.2011.02383.x]
18. Roy A, Kucukural A, and Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc. 2010; 5 (4): 725-38. [
DOI:10.1038/nprot.2010.5]